Healthcare Pharmaceutical Biotech

Sooner Discount Pharmacy LLC Strengthens Prescription Support for Norman Customers

July 14, 2026 9:45 AM

Sooner Discount Pharmacy LLC continues to support individuals and families in Norman by offering dependable prescription services, refill support, prescription transfers, auto Rx refills, and direct pharmacist consultations. Located at 1811 W Lindsey St., Norman, OK 73069-4101, the pharmacy remains focused on making everyday medication management easier and more accessible for local customers. As more patients look for convenient pharmacy...

Read more

VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations

July 14, 2026 9:00 AM

VSee Health, Inc. (Nasdaq:VSEE) ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its strategic initiatives and perspective on the role of artificial intelligence in healthcare and why enterprise telehealth platforms are well positioned to serve as the infrastructure layer for that transformation. "We believe healthcare is entering a new technology cycle in which...

Read more

Clinicians Have Become Healthcare's Human Middleware, New Vendor-Agnostic Report Finds from Black Book Research

July 14, 2026 8:55 AM

Black Book Research today released The Work That Didn't Disappear: The Black Book Clinician Reality Index, a nine-month national study finding that healthcare technology is frequently shifting work to clinicians rather than eliminating it. The vendor-agnostic survey of 1,919 clinicians found that 80.7% use at least one workaround every day, while 65.2% lose 30 minutes or more per day or shift to avoidable digital work. Clinicians reported...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Snapshot Recipes AI Powered Mobile App Hits New Milestone with Freemium Model and Strong Marketing Results

July 14, 2026 8:17 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a major evolution for its popular AI-powered mobile app, Snapshot Recipes, introducing a new freemium model designed to dramatically expand user access while accelerating growth. Download Snapshot Recipes for free now: https://snapshotrecipes.app/get/ Snapshot Recipes empowers users to create instant, personalized recipes by simply snapping a photo of their groceries, open fridge,...

Read more

Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery

July 14, 2026 8:00 AM

Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The Company will share these findings and showcase its Pivot™ tubeless insulin patch pump at the upcoming...

Read more

Fortified Health Security's 2026 Mid-Year Horizon Report Finds Healthcare Organizations Are Identifying More Cyber Risks Than They Can Fix

July 14, 2026 8:00 AM

Fortified Health Security (Fortified), a Best in KLAS managed security services provider (MSSP) specializing exclusively in healthcare cybersecurity, today released its 2026 Mid-Year Horizon Report, a free, biannual publication. The report reveals a growing challenge for the healthcare sector, with organizations gaining clearer visibility into cybersecurity risk while struggling to fix critical gaps quickly enough to keep pace with the volume...

Read more

Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant

July 14, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, today announced receipt of a Notice of Award for $5.3 million from the National Institutes on Drug Abuse (NIDA)1 to support the development of its novel MPAR® (Multi-Pill Abuse Resistance) overdose-protection...

Read more

Interim Report January - June 2026

July 14, 2026 1:40 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Second quarter 2026 (Apr-Jun) Net sales amounted to SEK 239.0 million (178.3), corresponding to a growth of 34 percent in SEK. Organic growth was 36 percent in local currencies. Excluding revenue from heart trials the organic growth was still 36 percent. Thoracic sales increased by 53 percent in local currencies and by 52 percent excluding revenue from heart trials. Abdominal sales increased by...

Read more

Americans for Ibogaine Welcomes Milestone as Federal Government Mobilizes Multiple Agencies to Advance Ibogaine Research and Psychedelic Medicine

July 14, 2026 1:15 AM

Americans for Ibogaine (AFI) today welcomed the coordinated, government-wide implementation of the Executive Order advancing psychedelic medicine, including a landmark HHS-VA partnership, new federal actions to accelerate ibogaine research, and efforts to prepare the healthcare system for the responsible deployment of future FDA-approved psychedelic therapies. Just 18 months ago, ibogaine and psychedelic medicine remained largely outside the...

Read more

The Light System to Host Live "Big Reveal" Event on July 21, Featuring $40,000 Product Giveaway to 20 Winners

July 14, 2026 12:55 AM

The Light System (TLS), a research backed wellness technology company known for its light and frequency based systems, announced today that it will host a live YouTube event on July 21 at 5:00 PM Eastern to unveil a new product the company has kept under wraps until now. The reveal will be paired with a giveaway valued at more than $40,000, with 20 individual winners selected during the broadcast. Details of the product itself are being withheld...

Read more

TramutoPorter Foundation to Celebrate 25th Anniversary with Gala at Camp Sunshine on July 30, 2026

July 14, 2026 12:00 AM

The TramutoPorter Foundation today announced plans for its 25th Anniversary Gala Celebration, to be held July 30, 2026, at Camp Sunshine in Casco, Maine. The milestone event will bring together partners, scholars, community leaders and supporters to celebrate 25 years of advancing compassionate leadership and to launch the Foundation's next chapter of impact through a mulit-million-dollar endowment commitment from Co-Founder Donato J. Tramuto....

Read more

Valaiss Reviews: What Customers and Independent Ingredient Research Say About the Swiss-Inspired Luxury Skincare Brand

July 13, 2026 6:45 PM

Shoppers searching "Valaiss reviews" are typically looking for two things: what the brand actually sells, and whether the ingredient claims hold up. Valaiss, the Swiss-inspired luxury skincare brand known for its Swiss Apple, Alpine Rose, Black Caviar, and Saffron formulations, is publishing its ingredient research directly to answer both questions with sourced, checkable information rather than marketing language alone. What Is Valaiss?...

Read more

American Kratom Association Warns Consumers Not to Let the 7-OH Industry Hijack HHS RFI

July 13, 2026 4:31 PM

The American Kratom Association (AKA) today warned natural kratom consumers not to be used as cover for the 7-OH industry, as manufacturers and vendors of chemically manipulated 7-hydroxymitragynine (7-OH) products urge consumers to flood the federal government with comments opposing the scheduling of those products. Source: American Kratom Association (AKA) (EZ Newswire) The 7-OH industry is encouraging natural kratom leaf consumers to submit...

Read more

Ameerex Advances North American Resource Program and Ameerex-Patagonia Lithium JV

July 13, 2026 4:00 PM

Ameerex Corporation, also known as HIRU Corporation (OTCID:HIRU), today provided an update on its North American resource program, including the Corcoran silver-gold project and its Canadian oilfield interests, alongside continued progress on the Ameerex-Patagonia lithium joint venture. North American Program Ameerex is advancing two North American projects: the Corcoran silver-gold project and a Canadian oilfield business. These projects will...

Read more

Desert Oasis Healthcare Uses AI Technology to Help Detect Heart Rhythm Conditions Earlier

July 13, 2026 10:00 AM

Desert Oasis Healthcare (DOHC) is using artificial intelligence (AI) and advanced patient data analysis to help identify people who may be at risk for undiagnosed heart rhythm conditions, known as arrhythmias, before those conditions lead to emergency room visits or hospitalizations. DOHC has implemented Predictive Arrhythmia Solutions™, an exclusive iRhythm Technologies program for healthcare systems that combines candidate identification AI...

Read more

As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo

July 13, 2026 9:27 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that it has received National Ethics Committee approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). The Company is now getting ready to file a Clinical Trial Application to ACOREP, the regulatory...

Read more

StressPal Study Published in JMIR Formative Research

July 13, 2026 9:10 AM

StressPal, a provider of evidence-based digital resilience interventions for healthcare professionals, today announced the publication of a study evaluating its StressPal Frontline: Essential Resilience Self-Care and Burnout Prevention program in JMIR Formative Research, an open access, peer-reviewed journal focused on emerging digital health innovations. The study, "Resiliency and Stress Among Healthcare Workers: A Quasi-Experimental Pre-Post...

Read more

Gemina Announces Private Placement Offering

July 13, 2026 8:45 AM

Gemina Laboratories Ltd. (the "Company" or "Gemina") is pleased to announce the launch of a private placement of common shares, offered exclusively to existing shareholders of the Company and subject to certain resale restrictions. Financing and Restructuring Update On December 30, 2025, the Company announced its plans to proceed with a non-brokered private placement of secured, non-convertible debentures (the "Debentures") for gross proceeds of...

Read more

Glioblastoma Foundation Marks 10 Years with New Push to Accelerate Personalized Treatment

July 13, 2026 8:00 AM

Over the past decade, the Glioblastoma Foundation has worked to advance research, educate patients and caregivers, support the glioblastoma community, and foster collaborations aimed at improving outcomes for individuals facing one of the most aggressive forms of cancer. As it enters its second decade, the Glioblastoma Foundation is expanding its efforts by building the infrastructure needed to advance precision medicine and therapeutic...

Read more

Hypha Labs (OTCQB:FUNI) Sees State-by-State Psilocybin Reform Creating the Next Major Growth Opportunity

July 13, 2026 8:00 AM

Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company developing advanced mushroom production technologies, believes the rapidly expanding state-by-state adoption of psilocybin programs is creating a significant long-term opportunity for scalable manufacturing infrastructure. With Oregon, Colorado, and New Mexico now operating statewide psilocybin programs and more than two dozen states considering medical, research, or decriminalization...

Read more